Currently, knee surgery is the most prevalent procedure performed on patients aged 45 years and older – totaling about 600,000 procedures in the U.S. and…
In 2014, A young woman in Snellville, Georgia visited her doctor with claims of depression. Her physician prescribed lamotrigine, also marketed under the tradename Lamictal,…
First established in the early nineties, the Manufacturer and User Facility Device Experience—or MAUDE—database is mandated reporting system maintained by the Food and Drug Administration…
Each year, more than 600,000 Americans have knee replacement surgery—a number that many believe will grow to one million within the next 10 years. Baby…
In the third consecutive talcum powder trial, a St. Louis City jury award plaintiff Deborah Giannecchini $2.57 million in compensatory damages and 67.5 million in…
Last week Childers, Schlueter & Smith, LLC published the Australian Health Hazard alert regarding the Stryker LFIT V40 Femoral head. CSS Firm has learned a…
The FDA just released more information on Invokana and Farxiga related to acute kidney failure. A topic and drug Childers, Schlueter & Smith have been…
An Invokana lawsuit filed last year in Canada seeks $1 billion in damages against drug maker Janssen Pharmaceuticals. The lawsuit, filed in September 2015 at…
The diabetes drug Invokana was introduced to the U.S. market in March 2013 and quickly became the go-to type 2 diabetes treatment, although the safety…
Although federal law requires the reporting of adverse events, no reports concerning power morcellators had been received by the U.S. Food and Drug Administration (FDA)…